During the last Small-Cap Friday column, I highlighted Synergy Pharmaceuticals (SGYP) as a new "Best Idea." It took the place of Relypsa (RLYP) on the list after that small biopharma concern was bought out with a 60% premium early Thursday by Swiss outfit GalenciaI have received a fair number of inquiries on what other small biotech names I like r...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.